Secondary Logo

Journal Logo

Full Text Access for Subscribers:

You can read the full text of this article if you:

Ovid Member Institutional Access
ARTICLE

Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID

Chapuis-Biron, Constance MD1; Kirchgesner, Julien MD2; Pariente, Benjamin MD, PhD3; Bouhnik, Yoram MD, PhD4; Amiot, Aurélien MD, PhD5; Viennot, Stéphanie MD6; Serrero, Mélanie MD7; Fumery, Mathurin MD, PhD8; Allez, Matthieu MD, PhD9; Siproudhis, Laurent MD, PhD10; Buisson, Anthony MD, PhD11; Pineton de Chambrun, Guillaume MD, PhD12; Abitbol, Vered MD13; Nancey, Stéphane MD, PhD14; Caillo, Ludovic MD15; Plastaras, Laurianne MD16; Savoye, Guillaume MD, PhD17; Chanteloup, Elise MD18; Simon, Marion MD19; Dib, Nina MD20; Rajca, Sylvie MD21; Amil, Morgane MD22; Parmentier, Anne-Laure23; Peyrin-Biroulet, Laurent MD, PhD24; Vuitton, Lucine MD, PhD1; the GETAID BioLAP Study Group

Author Information
The American Journal of Gastroenterology: November 2020 - Volume 115 - Issue 11 - p 1812-1820
doi: 10.14309/ajg.0000000000000810
  • Buy
  • SDC

Abstract

© 2020 by The American College of Gastroenterology